Comprehensive genomic profiling of the lung transcriptome in emphysema and idiopathic pulmonary fibrosis using RNA-Seq by Kusko, Rebecca L et al.
POSTER PRESENTATION Open Access
Comprehensive genomic profiling of the lung
transcriptome in emphysema and idiopathic
pulmonary fibrosis using RNA-Seq
Rebecca L Kusko1*†, John Brothers II2†, Gang Liu3, Lingqi Luo3, Brenda Juan Guardela4, John Tedrow4,
Yuriy Aleksyev1,5, Ivana V Yang6, Mick Correll7, Mark Geraci8, John Quackenbush7, Frank Sciurba4,
Marc Lenburg1,2,3,5, David A Schwartz6, Jennifer Beane3, Naftali Kaminski4, Avrum Spira1,2,3
From Beyond the Genome 2012
Boston, MA, USA. 27-29 September 2012
Background
As part of the Lung Genomics Research Consortium
(LGRC), we sought to characterize transcriptomic altera-
tions underlying the molecular pathogenesis of emphy-
sema and idiopathic pulmonary fibrosis (IPF) using
mRNA-Seq,and comparing to mRNAand microRNA
microarray data obtained from the same samples.
Methods
87 LGRC lung tissue samples were sequenced on the Illu-
mina GAIIx, generating 75 nt paired-end reads and
approximately 30-40 million reads per sample. Using
gapped aligner Tophat, an average of 85% of reads aligned
to hg19. Gene expression was quantified using Cufflinks
and Ensembl59 known gene annotation (n = 24,249
genes). All lung tissue samples used in this study, as well
as additional LGRC lung tissue samples, were run on Agi-
lent V2 human whole genome arrays and Agilent V3
human miRNA microarrays.
Results
Using a mixture model, expression of 6,359 genes was
detected, 9,538 genes were not detected, and 8,397 genes
were variably detected across all lung tissue samples.
Using a subset of 58 samples from subjects with IPF (n =
19), emphysema (n = 19) or control samples (n = 20), dif-
ferential gene expression was determined using a t test to
compare each disease state with control. The expression
levels of 1,770 genes differed between IPF and control, and
220 genes between emphysema and control (P < 0.001).
Genes that go up in both emphysema and IPF relative to
control were enriched for the p53/hypoxia pathway
(KEGG, Biocarta) by GSEA. Gene expression estimates
were highly correlated between the mRNA-Seq and array
datasets across the same samples; however, we identified
additional gene expression changes by RNA-Seq (either
not significant by or not assayed by microarray) and vali-
dated these by quantitative PCR. Array-based gene expres-
sion estimates from additional lung tissue samples not
sequenced, together with immunohistochemistry, con-
firmed the upregulation of the p53/hypoxia pathway in
emphysema and IPF. Using reads that aligned across
known splice junctions, we identified 5 emphysema-
associated and 19 IPF-associated alternative splicing
events. These events included the loss of exons and
changes to the 3’ UTR. Using qPCR and Nanostring, we
validated two examples of differential splicing, one of
which is shared by both chronic obstructive pulmonary
disease (COPD) and IPF and involved with the p53 path-
way. Finally, using miRconnX, miRNA microarray data
and mRNA-Seq, data were integrated with a prior network
of computationally predicted and experimentally validated
miRNA-mRNA interactions. miRNAs that co-vary with
differentially expressed p53/hypoxia genes in IPF and
emphysema were identified and validated using in vitro
miRNA perturbation studies.
Conclusions
Our data indicate that the lung transcriptome is altered
in emphysema and IPF, and suggest that these changes
may include alterations in gene expression that are regu-
lated by miRNA as well as disease-associated alterative
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splicing events that are shared between COPD and IPF.
Specifically we observed a shared upregulation of the
p53/hypoxia pathway and decreased expression of the
miRNAs that may regulate this pathway. Our data also
reveal disease-associated changes in known splice junc-
tions that that may affect gene regulation or protein
function. This unprecedented high-resolution view of the
lung transcriptome associated with IPF and COPD may
ultimately provide biomarkers of risk and response to
therapy as well as potential therapeutic targets.
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